Measure GFR by Nasal SensorNCT01274169
Measurment of GFR by Nasal Sensors
An observational study of Measure GFR by Nasal Sensor, run by Rambam Health Care Campus.
Trial summary
to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Measure GFR by Nasal Sensor
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Mar 2008to Mar 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: volunteers subjects with different stages of CKD
Who may be able to join
- adults between 18-70 yrs
Who cannot join
- subject under 18
About this study
to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology
- Conditions
- Measure GFR by Nasal Sensor
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jan 2011 (estimated)
- Study startMar 2008
- Study completionMar 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Measure GFR by Nasal SensorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
Sponsor and investigators
- Lead sponsor
- Rambam Health Care Campus
- Sponsor type
- University, hospital or other
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01274169
- Sponsor's protocol ID
- NANOCTIL
- Status last verified
- Feb 2008
- First submitted
- 10 Jan 2011
- Last updated
- 11 Jan 2011
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Jan 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measurment of GFR by Nasal Sensors
- ClinicalTrials.gov ID
- NCT01274169
- Acronym / sponsor ID
- NANOCTIL
- Conditions
- Measure GFR by Nasal Sensor
- Study type
- Observational
- Recruitment status
- Completed
- Lead sponsor
- Rambam Health Care CampusUniversity, hospital or other
- Study start
- Mar 2008
- Study completion
- Mar 2010
- First posted
- 11 Jan 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology
Study design
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- volunteers subjects with different stages of CKD
Key inclusion criteria (1 listed)
- adults between 18-70 yrs
Key exclusion criteria (1 listed)
- subject under 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Jan 2011.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Measure GFR by Nasal Sensor, run by Rambam Health Care Campus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Jan 2011. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2011.